20.500.12556/DiRROS-12435
Worldwide perspectives on venom allergy
Venom immunotherapy is the standard of care for people with severe reactions and has been proven to reduce risk of future anaphylactic events. There is a moral imperative to ensure production, supply and worldwide availability of locally relevant, registered, standardized commercial venom extracts for diagnosis and treatment. Insects causing severe immediate allergic reactions vary by region worldwide. The most common culprits include honeybees (Apis mellifera), social wasps including yellow jackets (Vespula and Dolichovespula), paper wasps (Polistes) and hornets (Vespa), stinging ants (Solenopsis, Myrmecia, Pachycondyla, and Pogonomyrmex), and bumblebees (Bombus). Insects with importance in specific areas of the world include the Australian tick (Ixodes holocyclus), the kissing bug (Triatoma spp), horseflies (Tabanus spp), and mosquitoes (Aedes, Culex, Anopheles). Reliable access to high quality venom immunotherapy to locally relevant allergens is not available throughout the world. Many current commercially available therapeutic vaccines have deficiencies, are not suitable for, or are unavailable in vast areas of the globe. New products are required to replace products that are unstandardized or inadequate, particularly whole-body extract products. New products are required for insects in which no current treatment options exist. Venom immunotherapy should be promoted throughout the world and the provision thereof be supported by health authorities, regulatory authorities and all sectors of the health care service.
allergy and immunology
venoms
Hymenoptera
bee venoms
wasp venoms
insecta
ants hornet
bumblebee
mosquitoes
venom immunotherapy
immunologic desensitization
alergija in imunologija
živalski strupi
kožekrilci
čebelji strupi
osji strupi
insekti
mravlje
sršen
čmrlj
komarji
imunoterapija z živalskimi strupi
imunološka desenzibilizacija
true
false
true
Elsevier
Angleški jezik
Ni določen
© 2019 The Authors
Neznano
2020-09-23 14:30:16
2020-09-23 14:30:16
2022-08-18 03:37:25
0000-00-00 00:00:00
2019
0
Velika Britanija
0
Soavtor iz Slovenije: Julij Selb;
"Korosec and Jakob were joint first authors" --> str. 1;
Nasl. z nasl. zaslona;
Opis vira z dne 8. 11. 2019;
Št. članka: 10067;
str. 1-11
iss. 10
Vol. 12
Oct. 2019
0000-00-00
Zaloznikova
Objavljeno
NiDoloceno
0000-00-00
0000-00-00
0000-00-00
616-097
1939-4551
10.1016/j.waojou.2019.100067
2048568945
522444313
RAZ_Korosec_Peter_i2019.pdf
RAZ_Korosec_Peter_i2019.pdf
1
C7FF2C15568B3980F7C9008F4E075B1F
696149de843060e23efefb53ee10e73c215cbbb44bd800876f5cc87c177d03d6
8d58869d-17b6-11ed-b6b8-001a4af901a5
https://dirros.openscience.si/Dokument.php?lang=slv&id=17303
https://www.worldallergyorganizationjournal.org/article/S1939-4551(19)31221-9/fulltext
1
https://dirros.openscience.si/Dokument.php?lang=slv&id=15001
Univerzitetna klinika za pljučne bolezni in alergijo Golnik
0
0
0